These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3570501)
1. Eosinophil chemotactic activity in allergic patients during the birch pollen season: the effect of immunotherapy. Rak S; Håkansson L; Venge P Int Arch Allergy Appl Immunol; 1987; 82(3-4):349-50. PubMed ID: 3570501 [TBL] [Abstract][Full Text] [Related]
2. Immunotherapy abrogates the generation of eosinophil and neutrophil chemotactic activity during pollen season. Rak S; Håkanson L; Venge P J Allergy Clin Immunol; 1990 Nov; 86(5):706-13. PubMed ID: 2229837 [TBL] [Abstract][Full Text] [Related]
3. The effect of immunotherapy on eosinophil accumulation and production of eosinophil chemotactic activity in the lung of subjects with asthma during natural pollen exposure. Rak S; Björnson A; Håkanson L; Sörenson S; Venge P J Allergy Clin Immunol; 1991 Dec; 88(6):878-88. PubMed ID: 1744358 [TBL] [Abstract][Full Text] [Related]
4. The formation of eosinophil and neutrophil chemotactic activity during a pollen season and after allergen challenge. Håkansson L; Rak S; Dahl R; Venge P J Allergy Clin Immunol; 1989 May; 83(5):933-9. PubMed ID: 2654257 [TBL] [Abstract][Full Text] [Related]
5. Priming of eosinophil adhesion in patients with birch pollen allergy during pollen season: effect of immunotherapy. Håkansson L; Heinrich C; Rak S; Venge P J Allergy Clin Immunol; 1997 Apr; 99(4):551-62. PubMed ID: 9111502 [TBL] [Abstract][Full Text] [Related]
6. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. Rak S; Löwhagen O; Venge P J Allergy Clin Immunol; 1988 Sep; 82(3 Pt 1):470-80. PubMed ID: 3170995 [TBL] [Abstract][Full Text] [Related]
7. [The effect of specific immunotherapy on serum eotaxin level in patients with pollinosis: preliminary studies]. Jahnz-Rózyk K; Głodzińska-Wyszogrodzka E; Rozyńska-Polańska R; Paluchowska E; Zabielski LS Pol Merkur Lekarski; 2001 Sep; 11(63):244-6. PubMed ID: 11761820 [TBL] [Abstract][Full Text] [Related]
8. Effects of immunotherapy on the inflammation in pollen asthma. Rak S Allergy; 1993; 48(17 Suppl):125-8; discussion 143-4. PubMed ID: 8109703 [TBL] [Abstract][Full Text] [Related]
9. The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis. Kopp MV; Brauburger J; Riedinger F; Beischer D; Ihorst G; Kamin W; Zielen S; Bez ; Friedrichs F; Von Berg A; Gerhold K; Hamelmann E; Hultsch ; Kuehr J J Allergy Clin Immunol; 2002 Nov; 110(5):728-35. PubMed ID: 12417881 [TBL] [Abstract][Full Text] [Related]
10. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy. Rak S; Heinrich C; Scheynius A Allergy; 2005 May; 60(5):643-9. PubMed ID: 15813810 [TBL] [Abstract][Full Text] [Related]
11. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form. Andri L; Senna G; Andri G; Dama A; Givanni S; Betteli C; Dimitri G; Falagiani P; Mezzelani P Clin Exp Allergy; 1995 Nov; 25(11):1092-9. PubMed ID: 8581842 [TBL] [Abstract][Full Text] [Related]
12. Oral immunotherapy in birch pollen hay fever. Taudorf E; Laursen LC; Lanner A; Björksten B; Dreborg S; Søborg M; Weeke B J Allergy Clin Immunol; 1987 Aug; 80(2):153-61. PubMed ID: 3301985 [TBL] [Abstract][Full Text] [Related]
13. Changes in cytokine production in vitro during the early phase of birch-pollen immunotherapy. Movérare R; Elfman L; Björnsson E; Stâlenheim G Scand J Immunol; 2000 Aug; 52(2):200-6. PubMed ID: 10931388 [TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity between deciduous trees during immunotherapy. I. In vivo results. Möller C; Dreborg S Clin Allergy; 1986 Mar; 16(2):135-43. PubMed ID: 3708791 [TBL] [Abstract][Full Text] [Related]
15. [Reproducibility and seasonal dependence of specific intranasal provocation tests in birch pollen allergy patients]. Klimek L; Reichenbach M; Mewes T; Mann W Laryngorhinootologie; 1997 Aug; 76(8):475-9. PubMed ID: 9376030 [TBL] [Abstract][Full Text] [Related]
16. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects. Ceuppens JL; Bullens D; Kleinjans H; van der Werf J; Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600 [TBL] [Abstract][Full Text] [Related]
17. Clinical data and inflammation parameters in patients with cypress allergy treated with sublingual swallow therapy and subcutaneous immunotherapy. Ventura MT; Carretta A; Tummolo RA; Buquicchio R; Arsieni A; Murgia N Int J Immunopathol Pharmacol; 2009; 22(2):403-13. PubMed ID: 19505393 [TBL] [Abstract][Full Text] [Related]
18. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. Rak S; Heinrich C; Jacobsen L; Scheynius A; Venge P J Allergy Clin Immunol; 2001 Dec; 108(6):921-8. PubMed ID: 11742269 [TBL] [Abstract][Full Text] [Related]
19. The seasonal symptoms of hyposensitized and untreated hay fever patients in relation to birch pollen counts: correlations with nasal sensitivity, prick tests and RAST. Viander M; Koivikko A Clin Allergy; 1978 Jul; 8(4):387-96. PubMed ID: 709787 [TBL] [Abstract][Full Text] [Related]